Transfusion · 2007 · 52 citations · 19 references
Life SciencesCardiologyCell BiologyCell TherapyStem Cell BiologyStem Cell BiotechnologyCell-based TherapiesHematopoietic DifferentiationHematopoietic Stem Cell BiologyHematopoietic Stem CellsCardiac Cell TherapyCardiomyocyte MaturationCd133 ExpressionCord Blood CellsHematopoietic Stem Cell DifferentiationHuman Stem Cell ModelsLineage-specific Gene ExpressionUmbilical Cord Blood Stem Cells
BACKGROUND: Recent findings on human hematopoietic stem cell (HSC) properties suggest a possible therapeutic role of human umbilical cord blood (UCB) HSC-based cellular therapies in the treatment of myocardial infarction. STUDY DESIGN AND METHODS: Nine UCB units were subjected to sequential red cell removal, freezing, and postthawing CD133+ HSC immunoselection by a clinical-grade, CE-approved, magnetic apparatus and microbead-coated anti-CD133 monoclonal antibody. Selected UCB CD133+ cells were cultured in vitro in medium supporting either endothelial or cardiomyocytic differentiation in parallel experiments. RESULTS: Immunoselection allowed recovery of 79 percent of initial CD133+ cells with a CD133+ cell purity of 81 percent, on average. Parallel cultures showed the appearance of endothelial markers (VE-cadherin, CD146, and KDR and bright expression of CD105), morphofunctional features of endothelium in endothelial-supporting cultures, of cardiac muscle proteins (troponin I and myosin ventricular heavy chain alpha/beta; MYHC) and specific gene expression (GATA4, NKX2.5, troponin I, and MYHC) in cardiomyocyte-oriented cultures. CONCLUSIONS: The appearance of both endothelial- and cardiomyocyte-like cells from parallel cultures of frozen-thawed-immunoselected UCB CD133+ cells by a clinical-grade method and previously reported data on lack of major signs of rejection of these cells in immunocompetent rats subjected to experimental liver damage suggest a possible role of these allogeneic HSCs in cell therapies designed for regenerative treatments of ischemic diseases of human myocardium.
19
Cardiomyocytes can be generated from marrow stromal cells in vitro
Shinji Makino, Keiichi Fukuda, Shunichirou Miyoshi et al. · Journal of Clinical Investigation · 1999 · 1.9K citations · Full text
Medicine, Cardiology, Cell Biology +13
Shao‐Liang Chen, Fang Wu-wang, Fei Ye et al. · The American Journal of Cardiology · 2004 · 1.2K citations